Cancer of lymphocytes in lymph nodes or lymphoid tissues
To support a 100% rating while disease is active or during treatment, records that show a confirmed diagnosis of non-Hodgkin's lymphoma and documentation of ongoing or recent treatment are central. Oncology notes, pathology or biopsy reports, imaging studies such as PET or CT scans, and treatment records from a hematologist or oncologist all reflect active disease or an active treatment phase. For the indolent, non-contiguous low-grade variant, records that specifically identify the subtype and describe its current status are relevant.
After treatment ends, the two-year continuation period is supported by records showing the date treatment stopped. When the mandatory two-year exam occurs, imaging results, lab work, and physician notes reflecting whether there is any sign of recurrence become the key evidence. If residuals remain after the disease is in remission, records and statements describing those specific ongoing problems, including how they affect your daily functioning and work, would be relevant to rating under the applicable residual diagnostic code.
Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.
